Dublin, April 04, 2022 (GLOBE NEWSWIRE) -- The "Antibody Cocktails Market, by Type, by Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is basically a combination or cocktail of two different antibodies. The rationale behind combining two antibodies in a cocktail approach is to minimize mutational viral escape.
Market Dynamics
The increasing adoption of inorganic strategies such as partnerships and agreements by key players in the market is expected to drive the market growth during the forecast period. For instance, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, entered into a strategic partnership by which F. Hoffmann-La Roche Ltd., will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will then be marketed and distributed by the Cipla's distribution network.
Key features of the study:
- This report provides an in-depth analysis of the global antibody cocktails market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antibody cocktails market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antibody cocktails market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody cocktails market
Key Topics Covered:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Pipeline Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Product Launches
- PEST Analysis
4. Global Antibody Cocktails Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Government Initiatives To Combat COVID-19
5. Global Antibody Cocktails Market, By Type, 2017 - 2028, (US$ Million)
- Overview
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- Monovalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Polyvalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Antibody Cocktails Market, By Indication, 2017 - 2028, (US$ Million)
- Overview
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- COVID-19
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- HIV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
7. Global Antibody Cocktails Market, By Distribution Channel, 2017 - 2028, (US$ Million)
- Overview
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
8. Global Antibody Cocktails Market, By Region, 2017 - 2028, (US$ Million)
9. Competitive Landscape
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aridis Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZene Immunome Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Celltrion Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
For more information about this report visit https://www.researchandmarkets.com/r/r41vxv
Attachment
